|
Volumn 13, Issue 6, 2003, Pages 575-576
|
Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy
|
Author keywords
Goniosynechiae; Intraocular pressure; Intravitreal triamcinolone; Iris neovascularization; Ischemic ophthalmopathy
|
Indexed keywords
TRIAMCINOLONE ACETONIDE;
ANTIINFLAMMATORY AGENT;
AGED;
ARTICLE;
CASE REPORT;
DISEASE COURSE;
EYE DISEASE;
HUMAN;
INTRAOCULAR PRESSURE ABNORMALITY;
ISCHEMIA;
ISCHEMIC OPHTHALMOPATHY;
NEOVASCULARIZATION (PATHOLOGY);
OPHTHALMOPLEGIA;
PENETRATING KERATOPLASTY;
PERTHES DISEASE;
PRIORITY JOURNAL;
VISUAL ACUITY;
VITREOUS HEMORRHAGE;
DRUG EFFECT;
EYE;
INJECTION;
INTRAOCULAR HYPOTENSION;
INTRAOCULAR PRESSURE;
IRIS;
MALE;
TREATMENT OUTCOME;
VASCULARIZATION;
VITREOUS BODY;
WALDENSTROEM MACROGLOBULINEMIA;
AGED;
ANTI-INFLAMMATORY AGENTS;
EYE;
HUMANS;
INJECTIONS;
INTRAOCULAR PRESSURE;
IRIS;
ISCHEMIA;
MALE;
NEOVASCULARIZATION, PATHOLOGIC;
OCULAR HYPOTENSION;
TREATMENT OUTCOME;
TRIAMCINOLONE ACETONIDE;
VISUAL ACUITY;
VITREOUS BODY;
VITREOUS HEMORRHAGE;
WALDENSTROM MACROGLOBULINEMIA;
|
EID: 0642281860
PISSN: 11206721
EISSN: None
Source Type: Journal
DOI: 10.1177/112067210301300611 Document Type: Article |
Times cited : (25)
|
References (5)
|